Medical Gases Market to reach $16.7 Billion, globally, by 2032 at 7.0% CAGR: Allied Market Research
03 août 2023 07h27 HE
|
Allied Market Research
Portland, OR, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Medical Gases Market by Product (Pure medical gases, Medical gases mixture), by Application...
Cardiovascular Devices Market revenue to cross USD 90 Billion by 2033, says Research Nester
10 juil. 2023 05h36 HE
|
Research Nester
New York, July 10, 2023 (GLOBE NEWSWIRE) -- The global cardiovascular devices market is estimated to grow at a CAGR of ~7% from 2023 to 2033. The market is estimated to garner a revenue of ~USD 90...
Therapeutic Respiratory Devices Market is projected to grow at a CAGR of 8.02% by 2033 : Visiongain
18 mai 2023 09h00 HE
|
Visiongain Reports Ltd
As per the report by Visiongain, the global Therapeutic Respiratory Devices Market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period...
Botulinum Toxin Market to Reach Valuation of USD 13.4 Bn at CAGR of 8.4% by 2032
08 mai 2023 06h42 HE
|
Market.Us
New York, May 08, 2023 (GLOBE NEWSWIRE) -- In terms of revenue, The global Botulinum Toxin Market is estimated to exceed US$ 13.4 billion by 2032 from USD 6.1 billion in 2022, expanding at a CAGR of...
Therapeutic Respiratory Devices Market is projected to grow at a CAGR of 8.02% by 2033 : Visiongain Reports Ltd
06 avr. 2023 07h30 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Therapeutic Respiratory Devices 2023-2033: Forecasts by Product (Inhalers (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Ventilators...
Therapeutic Respiratory Devices Market is projected to grow at a CAGR of 8.02% by 2033 : Visiongain Reports Ltd
16 mars 2023 11h29 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Therapeutic Respiratory Devices 2023-2033: Forecasts by Product (Inhalers (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Ventilators...
QSAM Biosciences Completes Enrollment of Initial Cohort in its Phase 1 Study of CycloSam® Targeting Metastatic Bone Cancer
28 févr. 2023 08h00 HE
|
QSAM Biosciences Inc.
Austin, TX, Feb. 28, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Global Healthcare Gamification Market Anticipated to Generate a Revenue of $9,040.9 Million and Rise at a CAGR of 11.0% during the Analysis Timeframe 2022-2031 [230-Pages] | Details by Research Dive
11 janv. 2023 09h00 HE
|
Research Dive
New York, USA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global healthcare gamification market is envisioned to garner $9,040.9 million in revenue and...
QSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders
10 janv. 2023 07h00 HE
|
QSAM Biosciences Inc.
AUSTIN, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Point of Care Ultrasound Market to hit USD 5.5 Billion by 2030, says Global Market Insights Inc.
22 nov. 2022 05h26 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The point of care ultrasound market value is set to reach USD 5.5 billion by 2030, according to a new research report by Global Market...